中华放射肿瘤学杂志
中華放射腫瘤學雜誌
중화방사종류학잡지
CHINESE JOURNAL OF RADIATION ONCOLOGY
2009年
6期
477-481
,共5页
习勉%刘孟忠%邓小武%张黎%黄晓延%蔡玲
習勉%劉孟忠%鄧小武%張黎%黃曉延%蔡玲
습면%류맹충%산소무%장려%황효연%채령
肝肿瘤/放射疗法%放射疗法%三维适形%体层摄影术%X线计算机%四维%剂量学
肝腫瘤/放射療法%放射療法%三維適形%體層攝影術%X線計算機%四維%劑量學
간종류/방사요법%방사요법%삼유괄형%체층섭영술%X선계산궤%사유%제량학
Liver neoplasm/radiotherapy%Radiotherapy,three-dimensional conformal%Tomo-graphy,X-ray computed,four-dimensional%Dosimetry
目的 应用四维CT确定原发性肝癌内靶体积(ITV),比较常规三维计划与四维计划、呼吸门控计划的靶区体积及剂量学差异.方法 选择12例肝癌患者,行四维CT扫描,在10个时相的CT图像中分别勾画GTV、CTV和危及器官.根据PTV_(3D)、PTV_(40)、PTV_(Gating)为每例患者分别设计三维计划、四维计划、呼吸门控计划.PIV_(3D)由CTV外扩常规的安全边界得到,PTV_(4D)由10个时相的CTV融合形成的ITV_(40)外扩摆位误差(SM)得到,PTV_(Gating)由呼气末3个时相的CTV融合形成的ITV_(Gating)外扩SM得到.比较3套计划中靶区体积和危及器官剂量学的差异.结果 12例患者PTV_(3D)均显著大于PTV4D及PTV_(Gating),其中5例患者PTV_(3D)较PTV_(4D)遗漏了部分靶区.四维计划、呼吸门控计划中危及器官的受照剂量均较三维计划降低,以肝最为显著.在不增加正常组织受照剂量的前提下,四维计划的处方剂量可由三维计划的(50.8±2.0)Gy提升至(54.7±3.3)Cy,而呼吸门控计划可进一步提升至(58.0±3.9)Gy.结论 应用四维CT可在三维适形放疗基础上缩小肝癌靶区,在保证覆盖肿瘤的同时减少正常组织的受照剂量,并提升靶区剂量;门控放疗可进一步缩小靶区,更有利于保护正常组织,尤其是对于肝呼吸动度较大的病例.
目的 應用四維CT確定原髮性肝癌內靶體積(ITV),比較常規三維計劃與四維計劃、呼吸門控計劃的靶區體積及劑量學差異.方法 選擇12例肝癌患者,行四維CT掃描,在10箇時相的CT圖像中分彆勾畫GTV、CTV和危及器官.根據PTV_(3D)、PTV_(40)、PTV_(Gating)為每例患者分彆設計三維計劃、四維計劃、呼吸門控計劃.PIV_(3D)由CTV外擴常規的安全邊界得到,PTV_(4D)由10箇時相的CTV融閤形成的ITV_(40)外擴襬位誤差(SM)得到,PTV_(Gating)由呼氣末3箇時相的CTV融閤形成的ITV_(Gating)外擴SM得到.比較3套計劃中靶區體積和危及器官劑量學的差異.結果 12例患者PTV_(3D)均顯著大于PTV4D及PTV_(Gating),其中5例患者PTV_(3D)較PTV_(4D)遺漏瞭部分靶區.四維計劃、呼吸門控計劃中危及器官的受照劑量均較三維計劃降低,以肝最為顯著.在不增加正常組織受照劑量的前提下,四維計劃的處方劑量可由三維計劃的(50.8±2.0)Gy提升至(54.7±3.3)Cy,而呼吸門控計劃可進一步提升至(58.0±3.9)Gy.結論 應用四維CT可在三維適形放療基礎上縮小肝癌靶區,在保證覆蓋腫瘤的同時減少正常組織的受照劑量,併提升靶區劑量;門控放療可進一步縮小靶區,更有利于保護正常組織,尤其是對于肝呼吸動度較大的病例.
목적 응용사유CT학정원발성간암내파체적(ITV),비교상규삼유계화여사유계화、호흡문공계화적파구체적급제량학차이.방법 선택12례간암환자,행사유CT소묘,재10개시상적CT도상중분별구화GTV、CTV화위급기관.근거PTV_(3D)、PTV_(40)、PTV_(Gating)위매례환자분별설계삼유계화、사유계화、호흡문공계화.PIV_(3D)유CTV외확상규적안전변계득도,PTV_(4D)유10개시상적CTV융합형성적ITV_(40)외확파위오차(SM)득도,PTV_(Gating)유호기말3개시상적CTV융합형성적ITV_(Gating)외확SM득도.비교3투계화중파구체적화위급기관제량학적차이.결과 12례환자PTV_(3D)균현저대우PTV4D급PTV_(Gating),기중5례환자PTV_(3D)교PTV_(4D)유루료부분파구.사유계화、호흡문공계화중위급기관적수조제량균교삼유계화강저,이간최위현저.재불증가정상조직수조제량적전제하,사유계화적처방제량가유삼유계화적(50.8±2.0)Gy제승지(54.7±3.3)Cy,이호흡문공계화가진일보제승지(58.0±3.9)Gy.결론 응용사유CT가재삼유괄형방료기출상축소간암파구,재보증복개종류적동시감소정상조직적수조제량,병제승파구제량;문공방료가진일보축소파구,경유리우보호정상조직,우기시대우간호흡동도교대적병례.
Objective To define individualized internal target volume (ITV) for hepatocellular car-cinoma using four-dimensional (4D) CT, and to compare the differences in target volume definition and dose distribution among 3D, 4D and respiratory-gated plans. Methods 4DCT scanning was obtained for 12 pa-tients with hepatoceUular. Gross tumor volume (GTV), clnical target volume (CTV) and normal tissues were contoured on all 10 respiratory phases of 4DCT images. The 3D, 4D and gated treatment plans were prepared for each patient using three different planning target volumes (PTVs): 1) PTV3D was derived from a single CTV plus conventional margins;2) PTV4D was derived from ITV4D, which encompassed all 10 CTVs plus setup margins (SMs);3) PTV_(Gating) was derived from ITV_(Gating), which encompassed 3 CTVs within ga-ting-window at end-expiration plus SMs. The PTV volume and dose distribution were compared among differ-ent plans. Results The PTV3D was the largest in all 12 patients, but still missed partial target volume in 5 patients when comparing with PTV4D. Both the 4D plans and the gated plans spared more normal tissues than the 3D plans, especially the hver. Without increasing normal tissue dose, the 4D plans allowed for increas-ing the calculated dose from (50.8±2.0) Gy (3D plans) to (54.7±3.3) Gy, and the gated plans could further increase the dose to (58.0±3.9) Gy. Conclusions The 4DCT-based plans can ensure optimal tar-get coverage with less irradiation of normal tissues and allow dose escalation when compared with 3D plans.Respiratory gated radiotherapy can further reduce the target volumes to spare more surrounding tissues, espe-cially for patients with large extent of respiratory mobility.